Related Experiment Video

Updated: May 1, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K

Atherosclerosis: current pathogenesis and therapeutic options

Christian Weber1, Heidi Noels

  • 1Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany. christian.weber@med.uni-muenchen.de

Nature Medicine
|November 9, 2011
PubMed

Insights

Coronary artery disease (CAD) involves lipid metabolism and inflammation. New research targets these pathways to complement lipid-lowering therapies for atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Molecular Biology

Background:

  • Coronary artery disease (CAD) is a major global health issue, primarily caused by atherosclerosis.
  • Atherosclerosis pathogenesis involves disrupted lipid metabolism and chronic arterial wall inflammation.
  • Leukocyte trafficking, chemokines, and their receptors are key regulators of this disturbed equilibrium.

Purpose of the Study:

  • To systematically review recent molecular mechanisms in lipid-related inflammation in atherosclerosis and CAD.
  • To explore translational developments and clinical strategies targeting these pathways.
  • To highlight novel therapeutic targets complementing existing lipid-lowering treatments.

Main Methods:

  • Systematic literature review of molecular mechanisms.
  • Analysis of genetic profiling studies in human CAD.
  • Survey of translational research and clinical strategies.

Main Results:

  • Discovery of new pro- and anti-inflammatory pathways linking lipid and inflammation biology.
  • Identification of genetic variations influencing human CAD.
  • Unveiling of diverse targetable mechanisms for atherosclerosis treatment.

Conclusions:

  • Targeting lipid-related inflammation offers a promising strategy to complement lipid-lowering therapies for CAD.
  • Understanding molecular mechanisms and immune responses is crucial for developing novel therapeutic interventions.
  • Further research into these pathways can lead to improved clinical strategies for managing atherosclerosis and CAD.

More Related Videos

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

6.9K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

7.7K

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655